This inventor holds 4 USPTO granted patents and 2 EPO patents. Top assignee: Dana-Farber-Cancer Institute Inc.. Active years: 2016-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016-2020
Title: Innovations of Kenneth F May, Jr.
Introduction
Kenneth F May, Jr. is a notable inventor based in Bozeman, MT (US), recognized for his contributions to the field of therapeutic peptides. With a total of four patents to his name, he has made significant strides in cancer treatment methodologies.
Latest Patents
His latest patents focus on compositions comprising peptides that immunospecifically bind to defined binding partners, such as MHC class I polypeptide-related sequence A (MICA). These patents detail methods of treating cancer in subjects using the disclosed compositions. Additionally, they include methods for isolating human antibodies from cancer patients following immunotherapy, showcasing his commitment to advancing cancer treatment.
Career Highlights
Kenneth is affiliated with the Dana-Farber Cancer Institute Inc., where he continues to innovate and contribute to cancer research. His work is pivotal in developing new therapeutic approaches that could potentially improve patient outcomes.
Collaborations
Some of his notable coworkers include Kai W Wucherpfennig and Bettina Franz, who collaborate with him in various research initiatives.
Conclusion
Kenneth F May, Jr. exemplifies the spirit of innovation in the medical field, particularly in cancer therapy, through his groundbreaking patents and collaborative efforts.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile